PRGO News and Press, Perrigo Company plc From 03/28/23

2023-03-28 09:16:22 ET The FDA announced Tuesday that a joint advisory committee meeting would be held in May to discuss the marketing application submitted by Perrigo ( NYSE: PRGO ) unit HRA Pharma for oral contraceptive Opill for Over-The-Counter (OTC) use. The agency's ...

Perrigo Announces New Date for Joint FDA Advisory Committee Meeting to Review Opill® Daily Oral Contraceptive for OTC Use PR Newswire DUBLIN , March 28, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Product...

2023-03-25 10:44:38 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For furthe...

2023-03-24 07:29:58 ET GSK ( NYSE: GSK ) said it disagrees with a California state court ruling in respect to the Goetz case related to the company's heartburn drug Zantac (ranitidine). The British pharma giant said that after 13 epidemiological studies conducted lookin...

2023-03-20 18:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-20 10:47:34 ET Perrigo ( NYSE: PRGO ) rose 1.4% amid a new long idea at Hedgeye as the analyst sees the challenges of 2022 behind the company. "With depleted inventory levels at retail for Cough & Cold, a better outlook for Oral Care from lower freight rate...

2023-03-11 02:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-07 12:27:30 ET Canaccord Genuity has initiated Perrigo ( NYSE: PRGO ) with a buy rating saying that the company's new focus on self-care products, notably private-label over the counter meds, is a positive along with synergies and cost savings. The firm has a $39 p...

2023-03-05 00:15:34 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For furthe...

Summary All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.3% and a median increase of 8.1%. There are thirty-two increases for next week, up from twenty-four last week. I've tr...